Prevalence of the use of dosimeters for ionizing radiation from fluoroscopy - a systematic literature review and meta-analysis
Abstract
This study aims to assess the prevalence of individual dosimeter use among workers exposed to ionizing radiation during fluoroscopy-guided procedures. Additionally, factors contributing to its use were identified. Studies were identified through searches in five databases on 13 April 2024. Additionally, snowballing techniques were employed. The review followed PRISMA guidelines and the CoCoPop model. A narrative synthesis, bibliometric analysis, and meta-analysis were performed. Study quality was assessed using the Joanna Briggs Institute checklist for prevalence studies. Fifty studies involving 11,067 individuals were included. Orthopedics/traumatology was the most studied specialty (46 %). Median use rates were: 24 %(IQR = 44 %) for eye lens dosimeters, 15 %(IQR = 13 %) for electronic real-time dosimeters, 27 %(IQR = 42 %) for wrist/finger dosimeters, 25 %(IQR = 23 %) for collar/thyroid dosimeters and 5 % for ankle dosimeter; 15 %(IQR = 78 %) reported no monitoring device. In 15 studies (30 %) with 4,188 individuals (38 %), the overall prevalence of "always" using whole-body dosimeters was 43 %[95 %CI:24-62]. By continent, the highest prevalence was found in Africa (75 %[95 % CI: 46-95]), while the lowest was in the "Americas" (33 %[95 % CI: 16-52]). Significant moderator effects were found: higher prevalence in "Africa" (p = 0.04), "gastroenterology" (p = 0.04), and "involving radiology" (p = 0.01); lower in "orthopedics" (p = 0.01) and "physicians" (p = 0.03). No…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 11,067 participants or records.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.